![]() Postmarketing reports: Stupor, delusions, aggressive behavior, paranoid reaction, manic reaction, pathological gambling, increased libido including hypersexuality, and impulse control symptoms Gastrointestinal Rare (less than 0.1%): Suicide attempt, suicide, suicidal ideation ![]() Uncommon (0.1% to 1%): Psychosis, euphoria, abnormal thinking, amnesia Very common (10% or more): Hallucinations (up to 21%)Ĭommon (1% to 10%): Insomnia, depression, anxiety, irritability, hallucinations, confusion, nervousness, abnormal dreams, agitation Postmarketing reports: Coma, delirium, hypokinesia, involuntary muscle contractions, gait abnormalities, paresthesia, EEG changes, tremor Psychiatric Uncommon (0.1% to 1%): Weakness, slurred speech, hyperkinesiaįrequency not reported: Falling asleep during activities of daily living, withdrawal-emergent hyperpyrexia (a syndrome resembling neuroleptic malignant syndrome) Nervous systemĬommon (1% to 10%): Dizziness/lightheadedness, ataxia, headache, somnolence, dystonia The more commonly reported adverse reactions have included nausea, dizziness/lightheadedness, and insomnia. For Healthcare ProfessionalsĪpplies to amantadine: compounding powder, oral capsule, oral capsule extended release, oral syrup, oral tablet, oral tablet extended release. Nausea, dizziness (lightheadedness), insomnia. ![]() Last updated on Feb 14, 2022.Īpplies to amantadine: oral conventional capsules, oral conventional tablets, oral extended-release tablets, oral extended-release capsules, oral oral solution. Medically reviewed by Philip Thornton, DipPharm.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |